SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Seawolf Therapeutics Debuts With $100 Million Series A

The Series A financing was backed by Versant Ventures, MPM BioImpact, Novartis Venture Fund and Eli Lilly and Company.

Related stories